Interviews
Asian target could bring bigger presence or more clients, William Huffman says.
1
Nuveen eyes more acquisitions after Schroders deal: CEO
2
Shein turns back to China after Vietnam warehouse experiment fails
3
Apple tests China's CXMT memory chips for iPhones, MacBooks
4
Google Ventures invests in Singapore biotech startup Engine Biosciences
5
Beyond the Buyout: Asia's secondaries boom meets a slower reality
More Stories
What F&B group Golden Gate’s delayed IPO says about PE exits
AI startup Acrab raises $130m in Vertex-backed Series B funding
Peak XV, EDBI join $700m funding round of AI startup Lumilens
Editor’s Take: The Week That Was – Aug 3 – 8
KV Asia said to be weighing exit from Indo personal care firm
Analysis
Last month, both China and Vietnam were hit with new U.S. tariffs of 12.5%.
Deals
CXMT is China’s largest chipmaker by market value.
Venture Capital
The new investor was joined by existing investor Odyssey Therapeutics in the funding round.
In contrast, several high-profile primary buyouts have continued to progress.
Singapore
Here are the top developments across Asia this week.
India
Profitability concerns and intense competition stunt investor enthusiasm.
Vietnam
The securities commission revoked Golden Gate’s public company status in July.
Orders nearly doubled from the previous quarter to about 44,000 units.
Lenders bet the region’s fast-growing affluent population will continue to underpin growth this year.
